Brain Research                          Pharma

NeuroCode AG has been GCP-approved by Regierungspräsidium Darmstadt (Germany) in January 2007.

In August 2007 NeuroCode presented a poster on the topic of Stress-induced changes by Neurexan^R in Budapest.

In Oktober NeuroCode presented two preclinical posters on the topic of  drug profiling and discrimination between typical and atypicla neuroleptics in Vienna.

In December NeuroCode will present two preclinical posters on the topic of extension of clinical use for pramipexol and differences between selegelin and rasagilin.